---
title: "Assessing Merlin (MRLN) Valuation After C-130J Autonomy Milestone With U S Special Operations Command"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288966892.md"
description: "Merlin (MRLN) completed the Critical Design Review for its C-130J autonomy program with U.S. Special Operations Command, driving a short-term stock rebound. However, the company faces significant valuation challenges due to negative equity and substantial annual net losses against low revenue. Analysts suggest focusing on future cash generation rather than distorted Price-to-Book ratios, noting mixed sentiment despite recent momentum."
datetime: "2026-06-07T17:33:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288966892.md)
  - [en](https://longbridge.com/en/news/288966892.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288966892.md)
---

# Assessing Merlin (MRLN) Valuation After C-130J Autonomy Milestone With U S Special Operations Command

Merlin (MRLN) has completed the Critical Design Review for its C-130J autonomy program with U.S. Special Operations Command, marking a key milestone that moves the AI flight system into aircraft integration and formal testing.

See our latest analysis for Merlin.

The C-130J design milestone has coincided with a sharp shift in sentiment, with Merlin’s 1-day share price return of 19.78% and 7-day share price return of 6.83% contrasting with a 90-day share price return that is down 17.94% and a 1-year total shareholder return that is down 16.38%. This suggests momentum has recently improved from a weaker medium term trend.

If this kind of defense focused autonomy story interests you, it could be a good moment to see what else is moving in AI powered aviation and defense, including 31 AI small caps

With Merlin’s shares rebounding in the short term but still down over the past year, and trading below the US$13 analyst price target, investors face a key question: is this genuine mispricing, or is the market already baking in future growth?

## Preferred Multiple of Price-to-Book: Is it justified?

Merlin closed at $8.60, yet its current P/B ratio is reported at around -6x, which immediately raises questions about how to think about valuation here.

P/B compares a company’s market value to its accounting equity, so when equity is deeply negative, the ratio stops being a useful yardstick and can give misleading signals. In Merlin’s case, the negative equity and resulting negative P/B are more a reflection of its balance sheet structure and early stage losses than a clean read on value.

Because of that, a simple multiple comparison does not really help you judge whether the current $830.1m market cap makes sense next to peers in the US Aerospace & Defense industry, where many companies have positive equity and more conventional P/B ratios. For Merlin, investors may need to focus more on future cash generation potential and funding needs rather than anchoring on this distorted multiple.

See what the numbers say about this price — find out in our valuation breakdown.

**Result: Preferred multiple of Price-to-Book (ABOUT RIGHT)**

However, there are clear pressure points, including ongoing annual net losses of $499.598m on revenue of just $7.685m, as well as reliance on successful program execution with key defense partners.

**Wall Street's queuing for one rocket.** While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

## Next Steps

With sentiment clearly mixed, it can be useful to see the full picture yourself instead of relying on headlines or short term moves. To weigh both sides of Merlin's story, take a close look at our breakdown of 2 key rewards and 3 important warning signs

## Looking for more investment ideas?

Do not stop with a single stock when you can quickly scan other opportunities that match different goals, risk levels, and income needs using focused screeners.

-   Target potential upside by reviewing companies flagged in the 49 high quality undervalued stocks that combine lower prices with stronger fundamentals.
-   Strengthen portfolio resilience by checking out the 61 resilient stocks with low risk scores for stocks with more conservative risk profiles.
-   Boost income potential by scanning high yield candidates using the 9 dividend fortresses.

_This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

### **New:** Manage All Your Stock Portfolios in One Place

We've created the **ultimate portfolio companion** for stock investors, **and it's free.**

• Connect an unlimited number of Portfolios and see your total in one currency  
• Be alerted to new Warning Signs or Risks via email or mobile  
• Track the Fair Value of your stocks  

Try a Demo Portfolio for Free

### Related Stocks

- [MRLN.US](https://longbridge.com/en/quote/MRLN.US.md)
- [RKLB.US](https://longbridge.com/en/quote/RKLB.US.md)

## Related News & Research

- [Evaluating Eastman Chemical (EMN) After Recent Share Price Momentum And Perceived Valuation Discount](https://longbridge.com/en/news/289197233.md)
- [Albemarle publishes investor presentation outlining strategy for energy storage, specialties businesses](https://longbridge.com/en/news/289334544.md)
- [Tate & Lyle Stock Up On $3.6 Bln Cash Deal To Be Bought By Ingredion](https://longbridge.com/en/news/289045735.md)
- [Wall Street Predicts GitLab Stock Will Soar 110%. Here’s Why.](https://longbridge.com/en/news/288966234.md)
- [Assessing Celanese (CE) Valuation After Recent Share Price Weakness](https://longbridge.com/en/news/289166397.md)